Navigation Links
Genetic and Proteomic Advances Pave the Way for Next-Generation Leukemia Therapies
Date:12/10/2011

ALL remains a leading cause of cancer death in young patients. There are multiple subtypes of ALL with different genetic abnormalities that influence disease outcome and response to therapy, but most current treatments affect all dividing cells, so new targeted therapies that might be effective against non-dividing cells may be required to improve the outcome of this disease.

With the introduction of novel genomic sequencing technologies, researchers can now identify genetic alterations including mutations, chromosomal rearrangements, and structural variations that drive the initiation and progression of leukemia and, importantly, may provide new targets for the development of novel therapies. Prior research had identified a new subtype of B-cell ALL with poor outcome and a gene expression profile similar to that of Philadelphia chromosome (Ph+) ALL (known as Ph-like ALL). Notably, Ph+ ALL is characterized by the expression of BCR-ABL1, which can be effectively treated with tyrosine kinase inhibitors such as imatinib.

To understand the genetic basis underlying Ph-like B-cell ALL, a cooperative research study composed of the Children's Oncology Group, St. Jude Children's Research Hospital, the National Institutes of Health, and British Columbia Genome Sciences Center analyzed the transcriptome (RNA sequence) of 11 Ph-like patients by next-generation sequencing. The team also conducted whole genome sequencing on two of the patients, a process that has become increasingly attractive to understand the full genetic profile of certain types of cancer patients.  

From detailed genetic analysis, new rearrangements, structural changes, and sequence mutations that activate tyrosine kinases and cytokine receptors were identified in 10 of the 11 cases studied. Importantly, these alterations were sensitive to kinase inhibition with existing treatments such as imatinib. The results suggest that the use of genomic sequencing can be used to identify the f
'/>"/>

SOURCE American Society of Hematology
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Signal Genetics Announces Launch of Next Generation Genetic Multiple Myeloma Predictive Testing Product-MyPRS Plus™
2. VolitionRX Subsidiary Enters Into its First Revenue-Generating Agreement to Profile Blood-Based Epigenetic Signatures
3. Abbotts Genetic Test for Acute Myeloid Leukemia Prognosis Cleared by FDA
4. Novel New Dog DNA Test Turns Breeders Into Genetic Matchmakers
5. Genetic Profile Identified for Alzheimers Patients Showing Heightened Response to Acceras Breakthrough Product Axona®
6. Good Start Genetics to Announce Validation Study Results for its Next-Generation DNA Sequencing Platform During an Oral Presentation at the 2011 Annual Meeting of the American Society for Reproductive Medicine (ASRM)
7. American College of Medical Genetics Applauds HHS Secretarys Decision to Expand Newborn Screening to Include Critical Congenital Heart Disease
8. Ambry Genetics Announces Launch of Their CancerArray™ Product and Services Utilizing aCGH Technology
9. The Leukemia & Lymphoma Society Available to Comment on FDA Approval of Seattle Genetics Adcetris, First New Treatment for Hodgkin Lymphoma Since 1977
10. Genetic Testing Can Help the US Cut Costs and Improve Health Care
11. Metamark Genetics Announces Cancer Cell Study Highlighting Discovery of Key Molecules that Drive Progression of Malignant Melanoma in Humans
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... March 27, 2015  The quality function within the ... products meet quality standards at every stage of the ... quality leaders also have the challenge of balancing quality ... Those who don,t effectively balance these priorities risk funding ... marketplace failure and regulatory scrutiny. For the ...
(Date:3/27/2015)... SALT LAKE CITY , March 27, 2015 ... Richard J. Linder has been appointed to the Company,s ... vacancy created by the death in November 2014 of board ... of Rich Linder to our Board of Directors ... Kelvyn Cullimore, Jr. , chairman and president of Dynatronics.  "Rich ...
(Date:3/27/2015)... TEMPLE, Texas , March 27, 2015 The ... relocate in April to a 5,000-square-foot building at 1802 South ... a geographic area designated by the City of ... Baylor Scott & White and the Central Texas Veterans Health ... office and laboratory space to early stage biotechnology and life ...
Breaking Medicine Technology:New Medical Device Quality Study Finds Regulatory Environment is Boosting Quality Spending, Especially for Large Companies 2Dynatronics Announces Appointment of Richard J. Linder to Board of Directors 2Temple Health & Bioscience District Relocates, Offers Office And Lab Space To Biotech Companies 2
... Calif., Oct. 3, 2011 VIVUS, Inc. (NASDAQ: ... presented at Obesity 2011:  The 29 th Annual ... Orlando, Florida. The presentations highlighted the long-term beneficial effects ... weight loss.  Specifically, Qnexa patients had significant improvement in ...
... KALONA, Iowa, Sept. 30, 2011 CIVCO Medical ... Andres Ramirez as Sales Director of Advanced Robotics ... international sales efforts for the Protura Robotic Patient ... System. (Logo:   http://photos.prnewswire.com/prnh/20110419/AQ85801LOGO ) ...
Cached Medicine Technology:Two-year Treatment With Qnexa Has Benefits Beyond Weight Loss 2Two-year Treatment With Qnexa Has Benefits Beyond Weight Loss 3Two-year Treatment With Qnexa Has Benefits Beyond Weight Loss 4Two-year Treatment With Qnexa Has Benefits Beyond Weight Loss 5Two-year Treatment With Qnexa Has Benefits Beyond Weight Loss 6CIVCO Appoints Andres Ramirez Sales Director of Advanced Robotics and Workflow Solutions 2
(Date:3/30/2015)... National Nutrition Month is an ... habits and commit to nutritious decisions that will affect their ... a recent study from the U.S. Department of Agriculture (USDA), ... Making healthy snack choices needs to be an essential piece ... on the go. , Each day, millions of Americans turn ...
(Date:3/29/2015)... 30, 2015 Over 50 million women ... to undiagnosed autoimmune, thyroid, or hormone disorders. , Dr. ... personally treated hundreds of patients dealing with these conditions, ... the treatment options for their ailments. Her new book, ... women living with fatigue, brain fog, and sleepless nights. ...
(Date:3/29/2015)... Adults who are comparing the different ... the web can now use the QuotesPros.com website for ... now be explored while researching the automated database now ... differences between what a term policy provides and what ... some men and women. Insurers typically provide base pricing ...
(Date:3/29/2015)... (PRWEB) March 29, 2015 The ... clinical trials and research, manage data results and ... their clients reach regulation standards. Contract research organizations ... medical device manufacturing sectors. Industry operators provide clients ... to late-stage clinical research for Food and Drug ...
(Date:3/29/2015)... California (PRWEB) March 29, 2015 ... a new transition from Pixel Film Studios, entitled TranSports. ... transitions made exclusively for Final Cut Pro X,” said ... our users the tools needed to effortlessly transition using ... introduces TranSports, a new and uniquely styled transition pack ...
Breaking Medicine News(10 mins):Health News:Benefits of Healthy Snacking — HealthyYOU Vending Machines Offer 21 Healthy Snack Selections for People on the Go 2Health News:Benefits of Healthy Snacking — HealthyYOU Vending Machines Offer 21 Healthy Snack Selections for People on the Go 3Health News:How to Turn Mid-life into the Good Life 2Health News:Permanent Life Insurance Quotes Now Offered Through Web Search System at Insurer Website Online 2Health News:Contract Research Organizations in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Contract Research Organizations in the US Industry Market Research Report from IBISWorld Has Been Updated 3Health News:Contract Research Organizations in the US Industry Market Research Report from IBISWorld Has Been Updated 4Health News:Introducing TranSports for Final Cut Pro X Users from Pixel Film Studios 2
... ... at conference, ATLANTA, Feb. 26 Pamela Bishop, head ... featured presenter at the,2008 Run Walk Ride Fundraising Conference (RWRFC) ... at 4:00 p.m. EST,providing an overview of ING,s successful cause-marketing ...
... Alimera Sciences has entered into a,second exclusive ... management -- specifically the reduction of reactive,oxygen species ... The agreement gives Alimera the exclusive option ... as triphenylmethanes, as a potential,treatment for ocular disorders ...
... FRANCISCO, Feb. 26 VIA Pharmaceuticals,Inc. (Nasdaq: VIAP ... for the treatment of cardiovascular disease, announced today that,James ... VIA,will present a company update at the Susquehanna Second ... at 1:30 p.m. ET at the W,Hotel in New ...
... high blood sugar condition linked to high mortality ... effort is needed to deal with the effects of ... Heart Association scientific statement released Monday. , The statement ... also known as hyperglycemia, in people hospitalized with acute ...
... Quality Cardiology Center Seeks End to Soaring Health Costs, ... Hospital,one of the nation,s leading cardiology treatment centers, announced ... for one of the most common types of,open heart ... Wichita,Eagle published this week. "After carefully studying our costs ...
... Stock Exchange Symbol: CYT ... http://www.cryocath.com ... leader in cryotherapy products to treat cardiac,arrhythmias, today announced that Chief ... 4, 2008. Effective April 7,2008, Ginette Gagne will take over the ...
Cached Medicine News:Health News:ING Run for Something Better to be Featured at 2008 Run Walk Ride Fundraising Conference 2Health News:ING Run for Something Better to be Featured at 2008 Run Walk Ride Fundraising Conference 3Health News:ING Run for Something Better to be Featured at 2008 Run Walk Ride Fundraising Conference 4Health News:Alimera Sciences Signs Second Agreement With Emory University for Potential Treatments Using New Class of Antioxidants 2Health News:Alimera Sciences Signs Second Agreement With Emory University for Potential Treatments Using New Class of Antioxidants 3Health News:National Effort Needed to Address Hyperglycemia in Heart Patients 2Health News:CryoCath Appoints New Chief Financial Officer 2
Angled, 7.5 mm tying platforms.,Titanium, 111 mm long, 6 mm tying platforms....
Gills Colibri forceps, very fine pointed tips....
Castroviejo tying forceps, tying platforms, straight, 0.3 mm teeth....
Microsurgical straight forceps made of titanium has straight shafts with smooth working surface. TCI working parts 6 mm from tips with round handle, diam. 6 mm, overall length 116 mm....
Medicine Products: